Clinical Trials Directory

Trials / Completed

CompletedNCT04215198

NEM® + KD PUR® Fish Oil Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Efficacy of the NEM® Brand Eggshell Membrane + KD PUR® Brand Fish Oil Combination (Move3™) Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
85 (actual)
Sponsor
ESM Technologies, LLC · Industry
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study is intended to evaluate the effect of the dietary supplement combination of NEM® brand eggshell membrane + KD PUR® brand fish oil versus placebo in reducing exercise-induced joint pain, stiffness \& cartilage turnover in healthy men \& women. Half of the study participants will receive NEM + fish oil, once daily, orally while the other half of the study participants will receive placebo, once daily, orally while performing an exercise regimen every other day for two weeks.

Detailed description

Moderate exercise can induce discomfort in joints when done infrequently or when done too intensely or for too long a period. This discomfort is often realized as either pain or stiffness in the joint that was the focus of the exercise. For example, one's knees will hurt after jogging for several miles, particularly if jogging for the first time. This study is intended to evaluate whether the combination of NEM® brand eggshell membrane + KD PUR® brand fish oil, commercially available as Move3™ can alleviate joint pain or stiffness, either directly following exercise or 12 hours post-exercise versus placebo. The study will also evaluate Move3's effect, on cartilage turnover via the cartilage degradation biomarker c-terminal cross-linked telopeptide of type II collagen (CTX-II). Participants will perform a minimum of 40 steps per leg utilizing an aerobics step at the clinical site. They will follow this exercise regimen on alternating days for 2 consecutive weeks. Changes in pain \& stiffness (immediate \& 12-hour) will be compared to both baseline and to the placebo group. Urine samples will also be collected at baseline and at the end of Week 1 \& Week 2. The change in CTX-II from baseline will be compared to the placebo group.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMove3™ (NEM® brand eggshell membrane + KD PUR® brand fish oil)Dietary supplement combination for the support of joint health.
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2018-09-20
Primary completion
2019-01-16
Completion
2019-01-16
First posted
2020-01-02
Last updated
2024-04-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04215198. Inclusion in this directory is not an endorsement.